Tristel (OTCMKTS:TSNLF – Get Free Report) is projected to issue its resultson Monday, October 19th. Analysts expect Tristel to announce earnings of $0.1122 per share and revenue of $33.75 million for the quarter.
Tristel Stock Performance
Shares of TSNLF opened at $5.74 on Friday. Tristel has a 12 month low of $5.00 and a 12 month high of $6.00. The stock has a fifty day moving average price of $5.74 and a 200 day moving average price of $5.54.
Tristel Company Profile
Tristel plc is a United Kingdom-based infection-prevention company that develops, manufactures and markets products used to clean and disinfect reusable medical devices. Its technologies are designed for healthcare environments where instruments must be rapidly decontaminated between patients, including settings that may not have access to large automated reprocessing systems.
The company’s product portfolio is centered on chlorine dioxide-based disinfectants, foams and wipes. These products are used for devices such as ultrasound probes, endoscopes and other non-lumened medical equipment, as well as for selected clinical surfaces and specialist applications.
Read More
- Five stocks we like better than Tristel
- Bank of America Stock Sell-Off Looks Like a Buying Opportunity
- AST SpaceMobile Is Down 67%—Could SpaceX’s Mobile Push Deepen the Selloff?
- GlobalFoundries’ $21 Billion Deal Could Change the Economics of Chipmaking
- Fundamental and Technicals Signals Align for Costco: Is the Stock Finally Breaking Out?
Receive News & Ratings for Tristel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tristel and related companies with MarketBeat.com's FREE daily email newsletter.
